// App-Quantinova.ai

TCT-175 : Safety and Complications Associated With the Use of Protamine in Percutaneous Coronary Intervention

Researchers

Presenter

  • Hussayn Alrayes

Principal Investigators

  • Ayman Alsaadi

  • Ahmad Alkhatib

  • Dhruvil Patel

  • Mohammad Alqarqaz

  • Tiberio Frisoli

  • Brittany Fuller

  • Akshay Khandelwal

  • Gerald Koenig

  • Brian O’Neill

  • Pedro Villablanca

  • Mohammad Zaidan

  • William O’Neill

  • Khaldoon Alaswad

  • Mir Basir

Medical Centers

  • Henry Ford Health, Detroit, Michigan, USA

  • Wayne State University, School of Medicine, Detroit, MI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Protamine Sulfate

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved